Navigation Links
Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
Date:3/28/2008

538,130 --

Total non-current liabilities 4,805,872 6,397,742

Total liabilities 29,135,219 17,443,424

MINORITY INTEREST 6,144,063 11,883,323

SHAREHOLDERS' EQUITY:

Common stock, $0.001 par value, 250,000,000

shares authorized, 71,333,586 issued and

outstanding, respectively 71,334 71,334

Paid-in-capital 8,842,009 8,842,009

Additional paid-in-capital 69,105 --

Statutory reserves 9,420,783 9,420,783

Retained earnings 113,964,778 95,371,137

Accumulated other comprehensive income 13,980,346 5,714,988

Total shareholders' equity 146,348,355 119,420,251

Total liabilities and shareholders'

equity $ 181,627,637 $ 148,746,998

TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES

REVENUE BY REGION

Three months

ended December 31,

2007 2006 Change

China $ 6,739,641 $ 6,793,469 - 0.8%

International $ 6,575,670 $ 9,793,691 -32.9%

Total $13,315,311 $16,587,160 -19.7%

Twelve months

ended December 31,

2007 2006 Change

China $22,476,135 $27,074,979 -17.0%

International $32,423,925 $39,715,487 -18.4%

Total
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
2. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
4. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
5. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
6. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
7. Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
8. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
11. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
Post Your Comments:
*Name:
*Comment:
*Email: